Read about our work on COVID-19 here.

|October 30, 2019


Panorama worked with a leading pharmaceutical cannabis company interested in donating their product to support investigation into alternatives to opioid medications, and provided strategic counsel on the best ways to collaborate with stakeholders across medical, philanthropic, and academic communities to scale impact.

Panorama interviewed key stakeholders – policy advisors, pharmaceutical leaders, medical researchers, and communication experts – to understand different perspectives on how this initiative could be most impactful. Learn more about our designing an innovative partnership to end abuse of opioids in the US.